Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.90% | 168.39 | 1.3% | $496.78m | |
| BIIB | Biogen Inc. | 0.65% | 230.76 | 1.3% | $480.84m | |
| CELG | Celgene Corporation | -0.62% | 94.83 | 1.3% | $471.13m | |
| GILD | Gilead Sciences, Inc. | -0.75% | 65.86 | 0.9% | $453.88m | |
| ILMN | Illumina, Inc. | -2.29% | 300.59 | 3.5% | $305.96m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.78% | 302.57 | 2.6% | $276.84m | |
| A | Agilent Technologies, Inc. | -0.29% | 68.91 | 1.6% | $198.64m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.78% | 165.73 | 1.9% | $176.80m | |
| EXAS | Exact Sciences Corporation | -0.16% | 96.04 | 25.3% | $171.72m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.80% | 127.23 | 2.0% | $150.06m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.31% | 86.66 | 4.3% | $118.53m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.37% | 117.57 | 14.7% | $114.20m | |
| INCY | Incyte Corporation | -0.48% | 76.83 | 2.5% | $105.26m | |
| IONS | Ionis Pharmaceuticals, Inc. | 0.09% | 67.46 | 8.2% | $98.12m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -2.49% | 65.86 | 9.2% | $93.34m |
Company Profile
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.